ZDA
STJ

Zweig-DiMenna Associates’s St Jude Medical STJ Stock Holding History

Zweig-DiMenna Associates’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-213,082
Closed -$17.1M – 271
2016
Q4 		$17.1M Buy
213,082
+41,546
+24% +$3.3M 1.23% 23
2016
Q3 		$13.7M Buy
+171,536
New +$13.8M 1.11% 33
2015
Q4 		– Sell
-5,800
Closed -$366K – 311
2015
Q3 		$366K Buy
5,800
+2,400
+71% +$171K 0.02% 164
2015
Q2 		$248K Sell
3,400
-400
-11% -$28.9K 0.01% 200
2015
Q1 		$249K Buy
+3,800
New +$253K 0.01% 241

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Zweig-DiMenna Associates's STJ Position: Q1 2017 in Review

Zweig-DiMenna Associates sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 213,082 shares — an estimated $17.1M sold.

Zweig-DiMenna Associates first reported a position in STJ in Q1 2015 and held it in 5 quarters. The position peaked at $17.1M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Zweig-DiMenna Associates reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 213,082 St Jude Medical shares in Q1 2017, an estimated $17.1M.
  • Zweig-DiMenna Associates first reported a position in St Jude Medical in Q1 2015 and held it in 5 quarters.
  • Zweig-DiMenna Associates's St Jude Medical position peaked at $17.1M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Zweig-DiMenna Associates's 13F filing for Q1 2017, filed 8 May 2017.